An MRM ‐Based Cytokeratin Marker Assay as a Tool for Cancer Studies: Application to Lung‐Cancer Pleural Effusions
Conclusion and clinical relevance: An MRM‐based CK assay for carcinoma studies can differentiate between the three lung‐cancer histological types using less‐invasive PE sampling providing potential therapy‐guiding information on patients that are inoperable.This article is protected by copyright. All rights reserved
Source: Proteomics. Clinical Applications - Category: Biochemistry Authors: Anna Perzanowska, Agnieszka Fatalska, Grzegorz Wojtas, Andrzej Lewandowicz, Agata Michalak, Grzegorz Krasowski, Christoph H. Borchers, Michal Dadlez, Dominik Domanski Tags: RESEARCH ARTICLE Source Type: research
More News: Adenocarcinoma | Biochemistry | Cancer | Cancer & Oncology | Carcinoma | Epithelial Cancer | Lung Cancer | Skin Cancer | Squamous Cell Carcinoma | Study